Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.

Boisen ML, Hartnett JN, Shaffer JG, Goba A, Momoh M, Sandi JD, Fullah M, Nelson DKS, Bush DJ, Rowland MM, Heinrich ML, Koval AP, Cross RW, Barnes KG, Lachenauer AE, Lin AE, Nekoui M, Kotliar D, Winnicki SM, Siddle KJ, Gbakie M, Fonnie M, Koroma VJ, Kanneh L, Kulakosky PC, Hastie KM, Wilson RB, Andersen KG, Folarin OO, Happi CT, Sabeti PC, Geisbert TW, Saphire EO, Khan SH, Grant DS, Schieffelin JS, Branco LM, Garry RF.

Sci Rep. 2018 Apr 12;8(1):5939. doi: 10.1038/s41598-018-24246-w.

2.

Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report.

Branco LM, Boisen ML, Andersen KG, Grove JN, Moses LM, Muncy IJ, Henderson LA, Schieffellin JS, Robinson JE, Bangura JJ, Grant DS, Raabe VN, Fonnie M, Zaitsev EM, Sabeti PC, Garry RF.

Virol J. 2011 Aug 15;8:404. doi: 10.1186/1743-422X-8-404. Erratum in: Virol J. 2011;8:480. Zaitsev, Eleina M [added].

3.

Lassa fever in post-conflict sierra leone.

Shaffer JG, Grant DS, Schieffelin JS, Boisen ML, Goba A, Hartnett JN, Levy DC, Yenni RE, Moses LM, Fullah M, Momoh M, Fonnie M, Fonnie R, Kanneh L, Koroma VJ, Kargbo K, Ottomassathien D, Muncy IJ, Jones AB, Illick MM, Kulakosky PC, Haislip AM, Bishop CM, Elliot DH, Brown BL, Zhu H, Hastie KM, Andersen KG, Gire SK, Tabrizi S, Tariyal R, Stremlau M, Matschiner A, Sampey DB, Spence JS, Cross RW, Geisbert JB, Folarin OA, Happi CT, Pitts KR, Geske FJ, Geisbert TW, Saphire EO, Robinson JE, Wilson RB, Sabeti PC, Henderson LA, Khan SH, Bausch DG, Branco LM, Garry RF; Viral Hemorrhagic Fever Consortium.

PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2748. doi: 10.1371/journal.pntd.0002748. eCollection 2014 Mar.

4.

Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection.

Branco LM, Grove JN, Boisen ML, Shaffer JG, Goba A, Fullah M, Momoh M, Grant DS, Garry RF.

Virol J. 2011 Oct 24;8:478. doi: 10.1186/1743-422X-8-478.

5.

Undiagnosed acute viral febrile illnesses, Sierra Leone.

Schoepp RJ, Rossi CA, Khan SH, Goba A, Fair JN.

Emerg Infect Dis. 2014 Jul;20(7):1176-82. doi: 10.3201/eid2007.131265.

6.

Serosurveillance of viral pathogens circulating in West Africa.

O'Hearn AE, Voorhees MA, Fetterer DP, Wauquier N, Coomber MR, Bangura J, Fair JN, Gonzalez JP, Schoepp RJ.

Virol J. 2016 Oct 3;13(1):163.

7.

Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak.

Boisen ML, Schieffelin JS, Goba A, Oottamasathien D, Jones AB, Shaffer JG, Hastie KM, Hartnett JN, Momoh M, Fullah M, Gabiki M, Safa S, Zandonatti M, Fusco M, Bornholdt Z, Abelson D, Gire SK, Andersen KG, Tariyal R, Stremlau M, Cross RW, Geisbert JB, Pitts KR, Geisbert TW, Kulakoski P, Wilson RB, Henderson L, Sabeti PC, Grant DS, Garry RF, Saphire EO, Branco LM, Khan SH; Viral Hemorrhagic Fever Consortium.

Viral Immunol. 2015 Feb;28(1):19-31. doi: 10.1089/vim.2014.0108.

8.

Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.

Saijo M, Georges-Courbot MC, Marianneau P, Romanowski V, Fukushi S, Mizutani T, Georges AJ, Kurata T, Kurane I, Morikawa S.

Clin Vaccine Immunol. 2007 Sep;14(9):1182-9. Epub 2007 Jul 18.

9.

A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.

Safronetz D, Mire C, Rosenke K, Feldmann F, Haddock E, Geisbert T, Feldmann H.

PLoS Negl Trop Dis. 2015 Apr 17;9(4):e0003736. doi: 10.1371/journal.pntd.0003736. eCollection 2015 Apr.

10.

Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.

Branco LM, Grove JN, Moses LM, Goba A, Fullah M, Momoh M, Schoepp RJ, Bausch DG, Garry RF.

Virol J. 2010 Nov 9;7:306. doi: 10.1186/1743-422X-7-306.

11.

Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report.

Grove JN, Branco LM, Boisen ML, Muncy IJ, Henderson LA, Schieffellin JS, Robinson JE, Bangura JJ, Fonnie M, Schoepp RJ, Hensley LE, Seisay A, Fair JN, Garry RF.

Virol J. 2011 Jun 20;8:314. doi: 10.1186/1743-422X-8-314.

12.

Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers.

Gale TV, Horton TM, Grant DS, Garry RF.

PLoS Negl Trop Dis. 2017 Sep 18;11(9):e0005943. doi: 10.1371/journal.pntd.0005943. eCollection 2017 Sep.

13.

Sequence variability and geographic distribution of Lassa virus, Sierra Leone.

Leski TA, Stockelman MG, Moses LM, Park M, Stenger DA, Ansumana R, Bausch DG, Lin B.

Emerg Infect Dis. 2015 Apr;21(4):609-18. doi: 10.3201/eid2104.141469.

14.

Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G.

Gabriel M, Adomeh DI, Ehimuan J, Oyakhilome J, Omomoh EO, Ighodalo Y, Olokor T, Bonney K, Pahlmann M, Emmerich P, Lelke M, Brunotte L, Ölschläger S, Thomé-Bolduan C, Becker-Ziaja B, Busch C, Odia I, Ogbaini-Emovon E, Okokhere PO, Okogbenin SA, Akpede GO, Schmitz H, Asogun DA, Günther S.

PLoS Negl Trop Dis. 2018 Mar 29;12(3):e0006361. doi: 10.1371/journal.pntd.0006361. eCollection 2018 Mar.

15.

Data set on Lassa fever in post-conflict Sierra Leone.

Shaffer JG, Schieffelin JS, Grant DS, Goba A, Momoh M, Kanneh L, Levy DC, Hartnett JN, Boisen ML, Branco LM, Garry RF; Viral Hemorrhagic Fever Consortium.

Data Brief. 2019 Jan 16;23:103673. doi: 10.1016/j.dib.2019.01.021. eCollection 2019 Apr.

16.

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.

Branco LM, Grove JN, Geske FJ, Boisen ML, Muncy IJ, Magliato SA, Henderson LA, Schoepp RJ, Cashman KA, Hensley LE, Garry RF.

Virol J. 2010 Oct 20;7:279. doi: 10.1186/1743-422X-7-279.

17.

Comparison of MagPix Assays and Enzyme-Linked Immunosorbent Assay for Detection of Hemorrhagic Fever Viruses.

Satterly NG, Voorhees MA, Ames AD, Schoepp RJ.

J Clin Microbiol. 2016 Dec 28;55(1):68-78. doi: 10.1128/JCM.01693-16. Print 2017 Jan.

18.

Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation.

Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, Conteh AS, Wagoner KD, McMullan LK, Bowen MD, Peters CJ, Ksiazek TG.

J Clin Microbiol. 2000 Jul;38(7):2670-7.

19.

Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.

Boisen ML, Cross RW, Hartnett JN, Goba A, Momoh M, Fullah M, Gbakie M, Safa S, Fonnie M, Baimba F, Koroma VJ, Geisbert JB, McCormick S, Nelson DK, Millett MM, Oottamasathien D, Jones AB, Pham H, Brown BL, Shaffer JG, Schieffelin JS, Kargbo B, Gbetuwa M, Gevao SM, Wilson RB, Pitts KR, Geisbert TW, Branco LM, Khan SH, Grant DS, Garry RF.

J Infect Dis. 2016 Oct 15;214(suppl 3):S203-S209. Epub 2016 Aug 11.

20.

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.

Safronetz D, Rosenke K, Westover JB, Martellaro C, Okumura A, Furuta Y, Geisbert J, Saturday G, Komeno T, Geisbert TW, Feldmann H, Gowen BB.

Sci Rep. 2015 Oct 12;5:14775. doi: 10.1038/srep14775.

Supplemental Content

Support Center